Health

CVCs based in the southern and midwestern US often end up getting overlooked. Here is an updated list of women dominating corporate venture capital in this region.

Wei Cong Seah will invest globally in early and growth-stage startups in technologies aligned with Genting Group’s diverse business lines.

High-Tech Gründerfonds' latest fund allows corporate LPs to invest in startups that are closer to providing financial return.

Angelini Ventures plans to broaden its investments in healthcare startups in the Asian region.

Siro Perez helped set up the biotech startup while he was partner at IP Group in Australia.

Managed by Global Brain, the new fund will mainly seek overseas startups focused on frontier biotech.

M&As and IPOs continue their upward trend in October, with healthcare having a standout month, characterised by big exits in the private and public markets.

The biotech producer will invest in and incubate external projects through New Ventures, as Chelsea Johnson joins from Atlas Venture to lead the unit.

After a year building ventures, Mark Yde is joining Ajinomoto Group Ventures to invest in healthcare, food and greentech.

Sanofi's venture arm is going against a pharma bear market by upping investments and hiking its fund to $1.4bn. Unit head Jason Hafler says AI opportunities are a big reason why.

Quantum is on the cusp of moving from research to commercial use and companies are exploring its potential for improving diagnostics and the discovery of new drugs.